EP 1254268 A1 20021106 - METHODS AND MATERIALS RELATING TO LEUCINE-RICH REPEAT PROTEIN-LIKE (LRR PROTEIN-LIKE) POLYPEPTIDES AND POLYNUCLEOTIDES
Title (en)
METHODS AND MATERIALS RELATING TO LEUCINE-RICH REPEAT PROTEIN-LIKE (LRR PROTEIN-LIKE) POLYPEPTIDES AND POLYNUCLEOTIDES
Title (de)
VERFAHREN UND MATERIALIEN IN VERBINDUNG MIT POLYPEPTIDEN UND POLYNUKLEOTIDEN, WELCHE LEUCIN-REICHEN REPEAT PROTEINEN (LRR-PROTEIN-ÄHNLICH) GLEICHEN
Title (fr)
PROCEDES ET MATIERES LIES A DES POLYPEPTIDES ET DES POLYNUCLEOTIDES DU TYPE PROTEINE REPETEE RICHE EN LEUCINE (DU TYPE PROTEINE LRR)
Publication
Application
Priority
- US 0103653 W 20010202
- US 49691400 A 20000203
- US 56087500 A 20000427
- US 67222100 A 20000927
Abstract (en)
[origin: WO0157261A1] The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted LRR protein-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from thymus (Hyseq clone identification numbers 16395938 (SEQ ID NO: 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted LRR protein-like polypeptides, and antibodies specific for such polypeptides.
IPC 1-7
IPC 8 full level
A61K 31/7088 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 3/10 (2006.01); A61P 5/14 (2006.01); A61P 7/02 (2006.01); A61P 7/04 (2006.01); A61P 7/06 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 11/00 (2006.01); A61P 11/02 (2006.01); A61P 13/12 (2006.01); A61P 17/00 (2006.01); A61P 17/02 (2006.01); A61P 17/04 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 21/00 (2006.01); A61P 21/04 (2006.01); A61P 25/00 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/28 (2006.01); A61P 27/02 (2006.01); A61P 27/14 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 31/22 (2006.01); A61P 33/06 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 9/16 (2006.01); C12N 9/64 (2006.01); C12N 15/09 (2006.01); C12P 21/02 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 1/16 (2017.12); A61P 3/10 (2017.12); A61P 5/14 (2017.12); A61P 7/02 (2017.12); A61P 7/04 (2017.12); A61P 7/06 (2017.12); A61P 9/04 (2017.12); A61P 9/10 (2017.12); A61P 9/12 (2017.12); A61P 11/00 (2017.12); A61P 11/02 (2017.12); A61P 13/12 (2017.12); A61P 17/00 (2017.12); A61P 17/02 (2017.12); A61P 17/04 (2017.12); A61P 19/02 (2017.12); A61P 19/10 (2017.12); A61P 21/00 (2017.12); A61P 21/04 (2017.12); A61P 25/00 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/18 (2017.12); A61P 25/28 (2017.12); A61P 27/02 (2017.12); A61P 27/14 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/22 (2017.12); A61P 33/06 (2017.12); A61P 35/00 (2017.12); A61P 37/00 (2017.12); A61P 37/02 (2017.12); A61P 37/06 (2017.12); A61P 37/08 (2017.12); C07K 14/47 (2013.01); C12N 9/16 (2013.01); C12N 9/6432 (2013.01); C12Y 304/21006 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0157261A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0157261 A1 20010809; WO 0157261 A9 20030904; AU 3666001 A 20010814; CA 2399649 A1 20010809; EP 1254268 A1 20021106; JP 2004500081 A 20040108
DOCDB simple family (application)
US 0103653 W 20010202; AU 3666001 A 20010202; CA 2399649 A 20010202; EP 01908834 A 20010202; JP 2001555884 A 20010202